ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v21i5.2800ppharm-2529Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWВоспалительные заболевания кишечника и молочные продуктыInflammatory Bowel Diseases and Dairy Productshttps://orcid.org/0000-0001-7308-7280ХавкинА. И.KhavkinAnatoly I.

Хавкин Анатолий Ильич, доктор медицинских наук, профессор, заведующий кафедрой гастроэнтерологии и диетологии им. А.В. Мазурина, руководитель Московского областного центра детской гастроэнтерологии и гепатологии НИКИ детства Минздрава Московской области, профессор кафедры педиатрии с курсом детских хирургических болезней Медицинского института ФГАОУ ВО НИУ «БелГУ» Минобрнауки России

115093, Москва, ул. Большая Серпуховская, д. 62

Anatoly I. Khavkin, MD, PhD, Professor

62, Bolshaya Serpukhovskaya Str., Moscow, 115093

gastropedclin@gmail.comhttps://orcid.org/0000-0002-4516-4194БогдановаН. М.BogdanovaNatalia М.

Богданова Наталья Михайловна, к.м.н.

Санкт-Петербург

Natalia М. Bogdanova MD, PhD

Saint-Petersburg

natasha.bogdanov@mail.ruhttps://orcid.org/0000-0002-4733-3262НалетовА. В.NalyotovAndrew V.

Налетов Андрей Васильевич, д.м.н., профессор

Донецк

Andrew V. Nalyotov MD, PhD, Professor

Donetsk

nalyotov-a@mail.ruМацынинаМ. А.MatsyninaMaria A.

Мацынина Мария Александровна, к.м.н.

Санкт-Петербург

Maria A. Matsynina, MD, PhD

Saint-Petersburg

m.matsynina@gmail.comhttps://orcid.org/0000-0003-3441-4626ЕрохинаМ. И.ErokhinaMaria I.

Ерохина Мария Ильинична, научный сотрудник отдела наследственных и метаболических болезней Научно-исследовательского клинического института детства 

Москва

Maria I. Erokhina, Head of the Department of Gastroenterology, Scientific Research Clinical Institution of Childhood

Moscow

 

НИКИ детства; БелГУРоссияResearch Clinical Institute of Childhood; Belgorod State UniversityRussian FederationСПбГПМУРоссияSaint-Petersburg State Pediatric Medical UniversityRussian FederationДонГМУ им. М. ГорькогоРоссияM. Gorky Donetsk State Medical UniversityRussian FederationСЗГМУ им. И.И. МечниковаРоссияI.I. Mechnikov North-Western State Medical UniversityRussian FederationНИКИ детстваРоссияResearch Clinical Institute of ChildhoodRussian Federation202420112024215455461Copyright © Хавкин А.И., Богданова Н.М., Налетов А.В., Мацынина М.А., Ерохина М.И., 20242024Хавкин А.И., Богданова Н.М., Налетов А.В., Мацынина М.А., Ерохина М.И.Khavkin A.I., Bogdanova N.М., Nalyotov A.V., Matsynina M.A., Erokhina M.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/2529

На сегодняшний день в большинстве стран Европы и Северной Америки наблюдается неуклонный рост распространенности воспалительных заболеваний кишечника (ВЗК). Данных о взаимосвязи употребления молочных продуктов и развития ВЗК немного, несмотря на вероятные биологические механизмы, связывающие данные продукты с этиопатогенезом заболевания. Исключение из рациона молочных продуктов обычно связано с возникновением диспепсических симптомов при их употреблении, что может указывать на обострение воспалительного процесса в кишечнике или о наличии лактазной недостаточности. Для пациентов с ВЗК характерна высокая распространенность остеопороза, а ограничение употребления молочных продуктов оказывает еще большее негативное влияние на состояние минеральной плотности костей. В свою очередь, коррекция диетотерапии у пациентов с ВЗК при наличии у них непереносимости молочных продуктов должна быть важной частью процесса лечения и профилактики осложнений заболевания.

At the moment, in most countries of Europe and North America, there has been a steady increase in the prevalence of inflammatory bowel diseases (IBD). There is little data on the correlation between dairy consumption and the development of IBD, despite the likely biological mechanisms linking these products with the etiopathogenesis of the disease. The exclusion of dairy products from the diet is usually associated with the occurrence of dyspeptic symptoms when they are consumed, which may indicate an exacerbation of the inflammatory process in the intestine or the presence of lactase deficiency. Patients with IBD are characterized by a high prevalence of osteoporosis, and limiting the consumption of dairy products has an even greater negative effect on the state of bone mineral density. In turn, correction of diet therapy in patients with IBD in the presence of intolerance to dairy products should be an important part of the treatment and prevention of complications of the disease.

воспалительные заболевания кишечникамолочные продуктыминеральная плотность костейвитамин Dinflammatory bowel diseasesdairy productsbone mineral densityvitamin DОтсутствует.Not specified.ReferencesХавкин А.И., Налетов А.В., Шумилов П.В. и др. Диетические аспекты лечения воспалительных заболеваний кишечника // Вопросы детской диетологии. — 2024. — Т. 22. — № 1. — С. 51–62. — doi: https://doi.org/10.20953/1727-5784-2024-1-51-62Khavkin AI, Nalyotov AV, Shumilov PV, et al. Dietary aspects in the treatment of inflammatory bowel disease. Pediatric Nutrition. 2024;22(1):51–62. (In Russ). doi: https://doi.org/10.20953/1727-5784-2024-1-51-62Basso PJ, Camara NOS, Sales-Campos H. Microbial-based therapies in the treatment of inflammatory bowel disease — an overview of human studies. Fron Pharmacol. 2018;9:1571. doi: https://doi.org/10.3389/fphar.2018.01571Basso PJ, Camara NOS, Sales-Campos H. Microbial-based therapies in the treatment of inflammatory bowel disease — an overview of human studies. Fron Pharmacol. 2018;9:1571. doi: https://doi.org/10.3389/fphar.2018.01571Налетов А.В., Шумилов П.В., Ситкин С.И. Эффективность пищевых волокон при воспалительных заболеваниях кишечника // Вопросы детской диетологии. — 2024. — Т. 22. — № 2. — С. 74–81. — doi: https://doi.org/10.20953/1727-5784-2024-2-74-81Khavkin AI, Nalyotov AV, Shumilov PV, Sitkin SI. The effectiveness of dietary fiber in inflammatory bowel disease. Pediatric Nutrition. 2024;22(2):74–81. (In Russ). doi: https://doi.org/10.20953/1727-5784-2024-2-74-81Collaborators GBDIBD. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi: https://doi.org/10.1016/S2468-1253(19)30333-4Collaborators GBDIBD. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi: https://doi.org/10.1016/S2468-1253(19)30333-4Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of populationbased data. Gastroenterology. 2019;156(5):1345–1353. doi: https://doi.org/10.1053/j.gastro.2019.01.002Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of populationbased data. Gastroenterology. 2019;156(5):1345–1353. doi: https://doi.org/10.1053/j.gastro.2019.01.002Хавкин А.И., Налетов А.В., Марченко Н.А. Воспалительные заболевания кишечника у детей: современные достижения в диагностике и терапии // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. — 2023. — Т. 33. — № 6. — С. 7–15. — doi: https://doi.org/10.22416/1382-4376-2023-33-6-7-15Khavkin AI, Nalyotov AV, Marchenko NA. Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(6):7–15. (In Russ). doi: https://doi.org/10.22416/1382-4376-2023-33-6-7-15Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology. 2022;162(4):1147– 1159. doi: https://doi.org/10.1053/j.gastro.2021.12.282Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology. 2022;162(4):1147– 1159. doi: https://doi.org/10.1053/j.gastro.2021.12.282Белоусова Е.А., Абдулганиева Д.И., Алексеева О.П. и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований // Альманах клинической медицины. — 2018. — Т. 46. — № 5. — С. 445–463. — doi: https://doi.org/10.18786/2072-0505-2018-46-5-445-463Belousova EA, Abdulganieva DI, Alekseeva OP, et al. Socio-demographic characteristics, features of the course and treatment options for inflammatory bowel diseases in Russia. The results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445–463. (In Russ). doi: https://doi.org/10.18786/2072-0505-2018-46-5-445-463Hess JM, Stephensen CB, Kratz M, Bolling BW. Exploring the links between diet and inflammation: dairy foods as case studies. Adv Nutr. 2021;12(Suppl 1):1S–13S. doi: https://doi.org/10.1093/advances/nmab108Hess JM, Stephensen CB, Kratz M, Bolling BW. Exploring the links between diet and inflammation: dairy foods as case studies. Adv Nutr. 2021;12(Suppl 1):1S–13S. doi: https://doi.org/10.1093/advances/nmab108Nieman KM, Anderson BD, Cifelli CJ. The effects of dairy product and dairy protein intake on inflammation: a systematic review of the literature. J Am Coll Nutr. 2021;40(6):571–582. doi: https://doi.org/10.1080/07315724.2020.1800532Nieman KM, Anderson BD, Cifelli CJ. The effects of dairy product and dairy protein intake on inflammation: a systematic review of the literature. J Am Coll Nutr. 2021;40(6):571–582. doi: https://doi.org/10.1080/07315724.2020.1800532Ulven SM, Holven KB, Gil A, Rangel-Huerta OD. Milk and dairy product consumption and inflammatory biomarkers: an updated systematic review of randomized clinical trials. Adv Nutr. 2019;10(Suppl 2):S239–S250. doi: https://doi.org/10.1093/advances/nmy072Ulven SM, Holven KB, Gil A, Rangel-Huerta OD. Milk and dairy product consumption and inflammatory biomarkers: an updated systematic review of randomized clinical trials. Adv Nutr. 2019;10(Suppl 2):S239–S250. doi: https://doi.org/10.1093/advances/nmy072Díaz-López A, Bulló M, Martínez-González MA, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr. 2016;55(1):349–360. doi: https://doi.org/10.1007/s00394-015-0855-8Díaz-López A, Bulló M, Martínez-González MA, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr. 2016;55(1):349–360. doi: https://doi.org/10.1007/s00394-015-0855-8Kempinski R, Arabasz D, Neubauer K. Effects of milk and dairy on the risk and course of inflammatory bowel disease versus patients’ dietary beliefs and practices: a systematic review. Nutrients. 2024;16(15):2555. doi: https://doi.org/10.3390/nu16152555Kempinski R, Arabasz D, Neubauer K. Effects of milk and dairy on the risk and course of inflammatory bowel disease versus patients’ dietary beliefs and practices: a systematic review. Nutrients. 2024;16(15):2555. doi: https://doi.org/10.3390/nu16152555Lopes MB, Rocha R, Lyra AC, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29(3):575–581. doi: https://doi.org/10.3305/nh.2014.29.3.7124Lopes MB, Rocha R, Lyra AC, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29(3):575–581. doi: https://doi.org/10.3305/nh.2014.29.3.7124Larussa T, Suraci E, Marasco R, et al. Self-prescribed dietary restrictions are common in inflammatory bowel disease patients and are associated with low bone mineralization. Medicina (Kaunas). 2019;55(8):507. doi: https://doi.org/10.3390/medicina55080507Larussa T, Suraci E, Marasco R, et al. Self-prescribed dietary restrictions are common in inflammatory bowel disease patients and are associated with low bone mineralization. Medicina (Kaunas). 2019;55(8):507. doi: https://doi.org/10.3390/medicina55080507Szilagyi A, Galiatsatos P, Xue X. Systematic review and metaanalysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2016;15(1):67. doi: https://doi.org/10.1186/s12937-016-0183-8Szilagyi A, Galiatsatos P, Xue X. Systematic review and metaanalysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2016;15(1):67. doi: https://doi.org/10.1186/s12937-016-0183-8Da Silva MS, Rudkowska I. Dairy nutrients and their effect on inflammatory profile in molecular studies. Mol Nutr Food Res. 2015;59(7):1249–1263. doi: https://doi.org/10.1002/mnfr.201400569Da Silva MS, Rudkowska I. Dairy nutrients and their effect on inflammatory profile in molecular studies. Mol Nutr Food Res. 2015;59(7):1249–1263. doi: https://doi.org/10.1002/mnfr.201400569Garcia C, Anto L, Blesso CN. Effects of milk polar lipids on DSS-induced colitis severity are dependent on dietary fat content. Nutrients. 2022;14(23):5145. doi: https://doi.org/10.3390/nu14235145Garcia C, Anto L, Blesso CN. Effects of milk polar lipids on DSS-induced colitis severity are dependent on dietary fat content. Nutrients. 2022;14(23):5145. doi: https://doi.org/10.3390/nu14235145Anto L, Warykas SW, Torres-Gonzalez M, Blesso CN. Milk polar lipids: underappreciated lipids with emerging health benefits. Nutrients. 2020;12(4):1001. doi: https://doi.org/10.3390/nu12041001Anto L, Warykas SW, Torres-Gonzalez M, Blesso CN. Milk polar lipids: underappreciated lipids with emerging health benefits. Nutrients. 2020;12(4):1001. doi: https://doi.org/10.3390/nu12041001Talebi S, Zeraattalab-Motlagh S, Rahimlou M, et al. The association between total protein, animal protein, and animal protein sources with risk of inflammatory bowel diseases: A systematic review and meta-analysis of cohort studies. Adv Nutr. 2023;14(4):752– 761. doi: https://doi.org/10.1016/j.advnut.2023.05.008Talebi S, Zeraattalab-Motlagh S, Rahimlou M, et al. The association between total protein, animal protein, and animal protein sources with risk of inflammatory bowel diseases: A systematic review and meta-analysis of cohort studies. Adv Nutr. 2023;14(4):752– 761. doi: https://doi.org/10.1016/j.advnut.2023.05.008Opstelten JL, Leenders M, Dik VK, et al. Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a European prospective cohort investigation. Inflamm Bowel Dis. 2016;22(6):1403–1411. doi: https://doi.org/10.1097/MIB.0000000000000798Opstelten JL, Leenders M, Dik VK, et al. Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a European prospective cohort investigation. Inflamm Bowel Dis. 2016;22(6):1403–1411. doi: https://doi.org/10.1097/MIB.0000000000000798Tsai KY, You JF, Tsai TY, et al. Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice. Intest Res. 2023;21(1):100–109. doi: https://doi.org/10.5217/ir.2021.00110Tsai KY, You JF, Tsai TY, et al. Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice. Intest Res. 2023;21(1):100–109. doi: https://doi.org/10.5217/ir.2021.00110Alavinejad P, Nayebi M, Parsi A, et al. Is dairy foods restriction mandatory for inflammatory bowel disease patients: a multinational cross-sectional study. Arq Gastroenterol. 2022;59(3):358–364. doi: https://doi.org/10.1590/S0004-2803.202203000-65Alavinejad P, Nayebi M, Parsi A, et al. Is dairy foods restriction mandatory for inflammatory bowel disease patients: a multinational cross-sectional study. Arq Gastroenterol. 2022;59(3):358–364. doi: https://doi.org/10.1590/S0004-2803.202203000-65Ugidos-Rodríguez S, Matallana-González MC, Sánchez-Mata MC. Lactose malabsorption and intolerance: A review. Food Funct. 2018;9(8):4056–4068. doi: https://doi.org/10.1039/c8fo00555aUgidos-Rodríguez S, Matallana-González MC, Sánchez-Mata MC. Lactose malabsorption and intolerance: A review. Food Funct. 2018;9(8):4056–4068. doi: https://doi.org/10.1039/c8fo00555aНалетов А.В., Свистунова Н.А. Оценка состояния микробиоты тонкой кишки у детей, находящихся на длительной безмолочной диете // Вопросы питания. — 2022. — Т. 91. — № 2. — С. 15–20. — doi: https://doi.org/10.33029/0042-8833-2022-91-2-15-20Naletov AV, Svistunova NA. Assessment of the state of the microbiota of the small intestine in children on a long-term dairy-free diet. Nutrition. 2022;91(2):15–20. (In Russ). doi: https://doi.org/10.33029/0042-8833-2022-91-2-15-20Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):738– 746. doi: https://doi.org/10.1016/S2468-1253(17)30154-1Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):738– 746. doi: https://doi.org/10.1016/S2468-1253(17)30154-1Cox SR, Lindsay JO, Fromentin S, et al. Effects of Low-FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158(1):176–188.e7. doi: https://doi.org/10.1053/j.gastro.2019.09.024Cox SR, Lindsay JO, Fromentin S, et al. Effects of Low-FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158(1):176–188.e7. doi: https://doi.org/10.1053/j.gastro.2019.09.024Lee AD, Spiegel BM, Hays RD, et al. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil. 2017;29(5):10. doi: https://doi.org/10.1111/nmo.13003Lee AD, Spiegel BM, Hays RD, et al. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil. 2017;29(5):10. doi: https://doi.org/10.1111/nmo.13003Bodini G, Zanella C, Crespi M, et al. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition. 2019;67–68:110542. doi: https://doi.org/10.1016/j.nut.2019.06.023Bodini G, Zanella C, Crespi M, et al. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition. 2019;67–68:110542. doi: https://doi.org/10.1016/j.nut.2019.06.023Prince AC, Myers CE, Joyce T, et al. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(5):1129–1136. doi: https://doi.org/10.1097/MIB.0000000000000708Prince AC, Myers CE, Joyce T, et al. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(5):1129–1136. doi: https://doi.org/10.1097/MIB.0000000000000708Jasielska M, Grzybowska-Chlebowczyk U. Lactose Malabsorption and Lactose Intolerance in Children with Inflammatory Bowel Diseases. Gastroenterol Res Pract. 2019;2019:2507242. doi: https://doi.org/10.1155/2019/2507242Jasielska M, Grzybowska-Chlebowczyk U. Lactose Malabsorption and Lactose Intolerance in Children with Inflammatory Bowel Diseases. Gastroenterol Res Pract. 2019;2019:2507242. doi: https://doi.org/10.1155/2019/2507242Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region. Pol Arch Intern Med. 2018;128(7-8):447–454. doi: https://doi.org/10.20452/pamw.4292Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region. Pol Arch Intern Med. 2018;128(7-8):447–454. doi: https://doi.org/10.20452/pamw.4292De Martinis M, Allegra A, Sirufo MM, et al. Vitamin D deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review. Int J Mol Sci. 2021;22(16):8855. doi: https://doi.org/10.3390/ijms22168855De Martinis M, Allegra A, Sirufo MM, et al. Vitamin D deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review. Int J Mol Sci. 2021;22(16):8855. doi: https://doi.org/10.3390/ijms22168855Gubatan J, Mitsuhashi S, Zenlea T, et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(2):240–246. e1. doi: https://doi.org/10.1016/j.cgh.2016.05.035Gubatan J, Mitsuhashi S, Zenlea T, et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(2):240–246. e1. doi: https://doi.org/10.1016/j.cgh.2016.05.035Mechie NC, Mavropoulou E, Ellenrieder V, et al. Distinct association of serum vitamin D concentration with disease activity and trough levels of infliximab and adalimumab during inflammatory bowel disease treatment. Digestion. 2020;101(6):761–770. doi: https://doi.org/10.1159/000502515Mechie NC, Mavropoulou E, Ellenrieder V, et al. Distinct association of serum vitamin D concentration with disease activity and trough levels of infliximab and adalimumab during inflammatory bowel disease treatment. Digestion. 2020;101(6):761–770. doi: https://doi.org/10.1159/000502515Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis. 2018;12(6):742–752. doi: https://doi.org/10.1093/ecco-jcc/jjy025Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis. 2018;12(6):742–752. doi: https://doi.org/10.1093/ecco-jcc/jjy025Хавкин А.И., Налетов А.В., Масюта Д.И., Махмутов Р.Ф. Роль витамина D в патогенезе воспалительных заболеваний кишечника: обзор литературы // Вопросы современной педиатрии. — 2024. — Т. 23. — № 2. — С. 58–62. — doi: https://doi.org/10.15690/vsp.v23i2.2722Khavkin AI, Nalyotov AV, Masyuta DI, Makhmutov RF. Role of Vitamin D in the Pathogenesis of Inflammatory Bowel Diseases: Literature Review. Voprosy sovremennoi pediatrii — Current Pediatrics. 2024;23(2):58–62. (In Russ). doi: https://doi.org/10.15690/vsp.v23i2.2722Wu Z, Liu D, Deng F. The role of vitamin D in immune system and inflammatory bowel disease. J Inflamm Res. 2022;15:3167–3185. doi: https://doi.org/10.2147/JIR.S363840Wu Z, Liu D, Deng F. The role of vitamin D in immune system and inflammatory bowel disease. J Inflamm Res. 2022;15:3167–3185. doi: https://doi.org/10.2147/JIR.S363840Shams-White MM, Chung M, Fu Z, et al. Animal versus plant protein and adult bone health: a systematic review and metaanalysis from the national osteoporosis foundation. PLoS One. 2018;13(2):e0192459. doi: https://doi.org/10.1371/journal.pone.0192459Shams-White MM, Chung M, Fu Z, et al. Animal versus plant protein and adult bone health: a systematic review and metaanalysis from the national osteoporosis foundation. PLoS One. 2018;13(2):e0192459. doi: https://doi.org/10.1371/journal.pone.0192459George KS, Muñoz J, Akhavan NS, et al. Is soy protein effective in reducing cholesterol and improving bone health? Food Funct. 2020;11(1):544–551. doi: https://doi.org/10.1039/c9fo01081eGeorge KS, Muñoz J, Akhavan NS, et al. Is soy protein effective in reducing cholesterol and improving bone health? Food Funct. 2020;11(1):544–551. doi: https://doi.org/10.1039/c9fo01081eWeaver CM, Alexander DD, Boushey CJ, et al. Calcium plus Vitamin D supplementation and risk of fractures: an updated metaanalysis from the National osteoporosis foundation. Osteoporos Int. 2016;27(1):367–376. doi: https://doi.org/10.1007/s00198-015-3386-5Weaver CM, Alexander DD, Boushey CJ, et al. Calcium plus Vitamin D supplementation and risk of fractures: an updated metaanalysis from the National osteoporosis foundation. Osteoporos Int. 2016;27(1):367–376. doi: https://doi.org/10.1007/s00198-015-3386-5Fabiani R, Naldini G, Chiavarini M. Dietary patterns in relation to low bone mineral density and fracture risk: a systematic review and meta-analysis. Adv Nutr. 2019;10(2):219–236. doi: https://doi.org/10.1093/advances/nmy073Fabiani R, Naldini G, Chiavarini M. Dietary patterns in relation to low bone mineral density and fracture risk: a systematic review and meta-analysis. Adv Nutr. 2019;10(2):219–236. doi: https://doi.org/10.1093/advances/nmy073Abreu S, Agostinis-Sobrinho C, Santos R, et al. Association of dairy product consumption with metabolic and inflammatory biomarkers in adolescents: A cross-sectional analysis from the LabMed study. Nutrients. 2019;11(10):2268. doi: https://doi.org/10.3390/nu11102268Abreu S, Agostinis-Sobrinho C, Santos R, et al. Association of dairy product consumption with metabolic and inflammatory biomarkers in adolescents: A cross-sectional analysis from the LabMed study. Nutrients. 2019;11(10):2268. doi: https://doi.org/10.3390/nu11102268Malmir H, Larijani B, Esmaillzadeh A. consumption of milk and dairy products and risk of osteoporosis and hip fracture: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020;60(10):1722– 1737. doi: https://doi.org/10.1080/10408398.2019.1590800Malmir H, Larijani B, Esmaillzadeh A. consumption of milk and dairy products and risk of osteoporosis and hip fracture: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020;60(10):1722– 1737. doi: https://doi.org/10.1080/10408398.2019.1590800Bordoni A, Danesi F, Dardevet D, et al. Dairy products and inflammation: A review of the clinical evidence. Crit Rev Food Sci Nutr. 2017;57(12):2497–2525. doi: https://doi.org/10.1080/10408398.2014.967385Bordoni A, Danesi F, Dardevet D, et al. Dairy products and inflammation: A review of the clinical evidence. Crit Rev Food Sci Nutr. 2017;57(12):2497–2525. doi: https://doi.org/10.1080/10408398.2014.967385Gonzalez S, Fernandez-Navarro T, Arboleya S, et al. Fermented dairy foods: Impact on intestinal microbiota and health-linked biomarkers. Front Microbiol. 2019;10:1046. doi: https://doi.org/10.3389/fmicb.2019.01046Gonzalez S, Fernandez-Navarro T, Arboleya S, et al. Fermented dairy foods: Impact on intestinal microbiota and health-linked biomarkers. Front Microbiol. 2019;10:1046. doi: https://doi.org/10.3389/fmicb.2019.01046Bischoff SC, Bager P, Escher J, et al. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2023;42(3):352–379. doi: https://doi.org/10.1016/j.clnu.2022.12.004Bischoff SC, Bager P, Escher J, et al. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2023;42(3):352–379. doi: https://doi.org/10.1016/j.clnu.2022.12.004

The authors declare that there are no conflicts of interest present.